DR. ADAM ESPIE ZIEMANN, M.D., PH.D.
Osteopathic Medicine in Iowa City, IA

License number
Iowa R-8748
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
200 Gh, Iowa City, IA 52242
Phone
(319) 356-1616
National Provider ID: 1851528095
LicenseFiles verified this license of Nov 7, 2017 at the National Plan and Provider Enumeration System.

Personal information

See more information about ADAM ESPIE ZIEMANN at radaris.com
Name
Address
Phone
Adam E Ziemann
200 Emrb, Iowa City, IA 52240
(319) 353-5573

Professional information

Adam E Ziemann Photo 1

Dr. Adam E Ziemann, Iowa City IA - MD (Doctor of Medicine)
Specialties:
Neurology
Age:
46
Address:
UNIVERSITY OF IOWA ANETHESIA
200 Hawkins Dr, Iowa City 52242
(319) 356-1749 (Phone), (319) 356-4505 (Fax)
UCSF NEUROLOGY
505 Parnassus Ave SUITE 114, San Francisco 94143
(415) 476-1489 (Phone), (415) 476-3428 (Fax)
Languages:
English
Hospitals:
UNIVERSITY OF IOWA ANETHESIA
200 Hawkins Dr, Iowa City 52242
UCSF NEUROLOGY
505 Parnassus Ave SUITE 114, San Francisco 94143
University of Iowa Hospital and Clinics
200 Hawkins Dr, Iowa City 52242
Education:
Medical School
R J & Lucille Carver Coll Med Univ Of Ia
Graduated: 2006

Adam Ziemann Photo 2

Method And Compositions For Treating And Preventing Seizures By Modulating Acid-Sensing Ion Channel Activity

US Patent:
2009029, Nov 26, 2009
Filed:
May 20, 2009
Appl. No.:
12/469037
Inventors:
MICHAEL J. WELSH - RIVERSIDE IA, US
JOHN A. WEMMIE - IOWA CITY IA, US
ADAM E. ZIEMANN - IOWA CITY IA, US
Assignee:
UNIVERSITY OF IOWA RESEARCH FOUNDATION - IOWA CITY IA
International Classification:
A61K 33/00, G01N 33/53, A61P 25/08
US Classification:
424700, 435 721
Abstract:
This invention provides novel methods and compositions for treating and preventing seizures by administration of ASIC1a receptor activating compounds. A novel method of assaying ASIC1a receptor activating compounds is included in the present invention. According to the invention applicants have demonstrated that seizure duration, intensity, and progression may be modulated by administration of an ASIC1a receptor activator which acts to increase the endogenous activity of ASIC1a receptors to mediate the effects of low pH in the CNS. The inventors have also found that the ASIC1a receptor activator may prevent such seizures altogether.

Osteopathic Medicine licenses in Iowa










Other Doctors licenses in Iowa